chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hurt her back when she reached down to pick up something / back was hurting; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the right arm) on 29Jan2021 (at the age of 59-years-old) as dose 1, single for COVID-19 immunisation. Medical history included ongoing arthritis in her back (diagnosed about 5 years ago). The patient's concomitant medications were not reported. The patient has no other vaccines on the same day of COVID vaccine. The patient hurt her back when she reached down to pick up something / back was hurting on 17Feb2021. The patient further reported that she has a question concerning if a medication will impact her next COVID vaccine dose. She had the first dose on 29Jan2021 and was scheduled for her second dose tomorrow. The patient stated that she hurt her back yesterday and the orthopedic doctor prescribed her a Methylpredisone Pack. She stated that she has not started it yet, because she saw that it was contraindicated with vaccines, so she was just wondering if that was accurate and if she should wait to start it until after taking her 2nd dose. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Still testing positive for COVID; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Still testing positive for COVID) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Janssens (Dose Number: 1  Batch/Lot No: 202A21A) on 07-Apr-2021. Past adverse reactions to the above products included No adverse event with Janssens. Concurrent medical conditions included Allergy, Asthma and Overweight. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.    On 02-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2022 at 12:30 PM, the patient experienced COVID-19 (Still testing positive for COVID). At the time of the report, COVID-19 (Still testing positive for COVID) had not resolved.            Patient started co-suspect pfizer on 12-May-2022 for indication treatment of COVID-19 and last administered date was 17-May-2022. Company comment: This spontaneous case concerns a 44-year-old, female patient with no relevant medical history, who experienced the unexpected, non-serious AESI of COVID-19. The event occurred 200 days after administration of an unknown dose of mRNA-1273. Patient was administered with first dose of Janssen, no information regarding other doses. Details of concomitant medications, clinical course, treatment and outcome were not provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 44-year-old, female patient with no relevant medical history, who experienced the unexpected, non-serious AESI of COVID-19. The event occurred 200 days after administration of an unknown dose of mRNA-1273. Patient was administered with first dose of Janssen, no information regarding other doses. Details of concomitant medications, clinical course, treatment and outcome were not provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.
I started to experience heart palpitations in Jan.  I am not entirely certain whether or not they started before or after the first vaccine.  I had never experienced them in the past and they briefly worsened after the second vaccine.
Extraordinarily burning pain; Itchiness all over body; Rash; Couple of hives; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Extraordinarily burning pain), PRURITUS (Itchiness all over body), RASH (Rash) and URTICARIA (Couple of hives) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included DROSPIRENONE, ETHINYLESTRADIOL (GIANVI) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced BURNING SENSATION (Extraordinarily burning pain), PRURITUS (Itchiness all over body), RASH (Rash) and URTICARIA (Couple of hives). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (Extraordinarily burning pain), RASH (Rash) and URTICARIA (Couple of hives) had resolved and PRURITUS (Itchiness all over body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt arrived for hydronephrosis due to obstruction of ureter.  Pt was found to be COVID positive.
Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion); Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) in a 24-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  There were no power outages that would have impacted the Moderna vaccine. However, the facility was unable to download the digital data logger and needed to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022.  No adverse reactions were reported by the patient.  No treatment medication was provided.
dizziness; Nausea; headache; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (dizziness), NAUSEA (Nausea) and HEADACHE (headache) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood pressure (Mentions high blood pressure) since an unknown date and Cholesterol since an unknown date.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced DIZZINESS (dizziness), NAUSEA (Nausea) and HEADACHE (headache). At the time of the report, DIZZINESS (dizziness), NAUSEA (Nausea) and HEADACHE (headache) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient takes regular medication for her high blood pressure and high cholesterol.  Treatment details: Advil (ibuprofen).
The medical history included 2 episodes of kidney stones and urinary retract infection. There were no known allergies, however, it was reported that the vaccinee had "poor tolerance to anesthetics." The PT had no history of joint complaints, gout, psoriasis, Lyme disease, or Crohn's disease. There was no family history of rheumatoid arthritis or lupus. Concurrent medications included conjugated estrogens (Premarin). The PT's husband was diagnosed w/Lyme disease and since the PT had the same exposure as the husband, she chose to receive her first injection of LYMErix in 1999. 2 wks later, in June 99, she began to experience an aggravation of painful pruritic dermatitis. The allergist / immunologist reported that the PT has had episodes of painful pruritic dermatitis for the past 3 yrs. The dermatitis covered the entire body w/the exception of the face. At the time of this report, the PT has not been treated, since "the MD is trying to make a definite diagnosis first." The allergist / immunologist considered the event to be possibly related to LYMErix administration. Lab studies performed in Feb. 2000 revealed uric acid 5.5 mg/dL, hemoglobin 12.9 g/dL, white blood cell count 5,500/cumm w/a normal differential and negative antinuclear antibodies. Punch biopsy demonstrated "perivascular lynphocytic infiltrate with rare eosinophils." A nasal swab was positive for eosinophils. As of 12/16/02, the outcome of the dermatitis was unknown.
Red, swollen, very hot, itch area approximately 3 inches around injection. Patient felt achy, fatigue, headache and sore arm lasting 3 days at time of reporting. Treatment with tylenol, benadryl cream and sleep. Previous bad reaction for patient with last tetanus shot (approximately 9 years ago...dime size swelling that popped & leaked oozing liquid)...possible patient allergy?
The morning after the vaccine, it started out as a circle around the vaccine site as described in the paperwork that that could happen. I called the doctors around the 15th to let them know it was expanding. By the 17th it had gotten pout of control and I was sending  the doctor pictures. The doctor gave her antibiotics and prednisone because it was spreading around her arm and down towards her elbow, it looked like a cellulitis infection. I had see a cellulitis infection before and that is what it reminded me of. all in all it did not heal for a week or two, the whole ordeal was about one to two weeks. It was nasty. So, it was almost a month long ordeal.
Patient came in today (10/9/17) and complaining of severe pain in the upper right arm where the shot was given. She said she couldn't move the arm. But there is no swelling or redness at the site of the injection. She also complained of tingling in  the lower arm occasionally when she moved her fingers and arm. I advised patient to use TYLENOL and can use ice pack as needed to get relief from pain.
This spontaneous report as received from a nurse on 13-NOV-2014 refers  to 2 unspecified patients. In November 2014 (either 11-NOV-2014 or 12-NOV-2014, the exact date was unknown) the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX (lot #, expiration date and route unspecified). No adverse symptoms reported. The temperature excursions for (Oka/Merck) VARIVAX was a supported excursion with long term stability data. Additional information has been requested.
Approx. 15 min after vaccine administration patient developed hives to site where injection was administered and around to back. No breathing problems occurred. Pt. was given topical steroid cream and hives resolved approx. 4 days later.
sick for a week after the shot; Initial information was received on 12-Oct-2021 regarding an unsolicited valid non-serious case received from social media from consumer/non-health care professional via Medical information (under reference number - US-SA-SAC20211016000311).   This case involves adult patient of unknown age and gender who experienced sick for a week (malaise), after receiving vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, concomitant medication(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sick for a week (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  No additional laboratory data was reported.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on batch number for this case.
Pt with diabetes and obstructive sleep apnea, as well as paroxysmal Afib, arrived to the hospital with increased shortness of breath and an increased heart rate.
large indurated, painful lesion @ site persisting until present date;pt initially could not lift arm w/o pain x 3 days;
Vaccinated two years ago, shingles now/ Suspected vaccination failure; Horrible case of shingles on back and chest and down the inside of his arm.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported for reporter's husband. The age at vaccination was not reported. The reporter stated he got vaccinated Shingles shot two years before reporting time and the patient was dealing with a horrible case of shingles on part of his back, chest and down the inside of his arm. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
She reported feeling dizzy and like she might faint.  Blood pressure was 180/100 11:45 tried sitting up and was dizzy blood pressure was 148/88 Ate some food and drank water At 12pm was feeling much better and bp was 138/80 (stated that was her normal range ] She walked out of building and was feeling good
Fainting, dizziness, blurred vision, sweating, feeling clammy, blood pressure dropping and sugar dropping.
Saturday 4/1: Extremely tired around 1:00 pm  quarter-size redness around shot site Sunday 4/2: lime size redness around shot site, spotty rash down inside of arms, torso, groin, headache in the afternoon
flu /suspected vaccination failure; flu; sick / it was the aluminum and the mercury and other contaminants, that where in the vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), influenza and sickness. On an unknown date, the outcome of the vaccination failure, influenza and sickness were unknown.   It was unknown if the reporter considered the vaccination failure, influenza and sickness to be related to Flu vaccine.  Additional case details were reported as follows: The age at vaccination was not reported. When patient took the vaccine, it was the aluminum and the mercury and other contaminants, that where in the vaccine that made the patient sick right away. Because of that patient did not take nay vaccine. It has been a long time since patient had the flu. This case was considered as suspected vaccination failure as details regarding laboratory test confirmation and time to onset for the event was unknown at the time of reporting. The follow up was not required.
LIGHTHEADED, DIZZY BLURRY VISION, NAUSEATED ALL DAY AND NIGHT. FELT BETTER THE NEXT DAY AT 3AM WHEN SHE WOKE UP.
Achy; Unable to stand up; Nausea; Can't hold food down; Cold; Throwing up/Vomiting; Headache; Muscle pain; Joint pain; Slight fever; Chills; Unable to sleep; Very weak; Feeling unwell; This is a spontaneous report from a contactable consumer. This consumer reported for a 69-year-old female patient.  A 69-years-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch number: Not reported/Lot Number: EW0170, expiration date: Unknown), via an unspecified route of administration, administered in left arm on 01May2021 (Age at the vaccination 69 years), as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8737), via an unspecified route of administration, administered in left arm on 10Apr2021 (age at the vaccination 69 years), as DOSE 1, SINGLE for COVID-19 immunization and she had no side effects. On 02May2021 the patient experienced headache, muscle pain, joint pain, throwing up/vomiting, cold. On an unspecified date in May2021, the patient experienced chills, slight fever, feeling unwell, achy, unable to stand up, unable to sleep, very weak. On 04May2021 the patient experienced nausea, can't hold food down. The reporter was calling on behalf of his mother and stated that his mother had her second dose of the COVID vaccine on 01May2021. That same day, she had no symptoms. The day after she started coming down with a cold. Until now she had been getting worse. Yesterday she started vomiting. She can't hold food down. She had a headache, muscle pain, joint pain, and nausea. She was feeling unwell. She was vomiting. It was reported that the vomiting started yesterday noting that she cannot hold down any food or liquids. It was reported that she was very weak adding that right now she did not have a fever. Reporter started that 45 minute to one hour ago she vomited when she tried to have a piece of bread and some water. She was able to walk by herself today and not as achy today. Reporter stated his concern was being able to sleep and hold food down without vomiting. Reporter stated that his friends experienced the same thing, and it only lasted a day or two. She needed guidance on what to do next. She did not have a prescribing doctor. She got the vaccine at the local pharmacy. She got her first vaccine on 10Apr2021. She had no side effects after the first one. First lot: ER8737. She got both shots in her left arm. The outcome of the events headache, muscle pain, joint pain, nausea, throwing up/vomiting, cold, can't hold food down was not resolved. The outcome of the events chills, slight fever, feeling unwell, achy, unable to stand up, unable to sleep and very weak was unknown.   No follow-up attempts are needed. No further information is expected.
One week post vax, the pt experienced swelling and a rash at the injection site. The child was seen by a physician and treated at the office. The most recent information received on 2/11/00 reports the condition of the pt as unknown.
12 year old client was administered the Moderna Vaccine in error.  No adverse reactions noted after the vaccine was administered. His mother did not report any adverse reactions as well. Encouraged to monitor for an adverse reactions such as breathing pattern, dyspnea, stomach discomfort,
2-18-15, Had itching, pain, outbreak on Lt. hip then, it moved to bottom of spine very painful red stripe appeared. Went to "walk in clinic" seen Dr. He said it's shingles, BATCROBAN 2% cream, and antibiotic. Also tried antiviral medicine. I told him  "Doc" I just had my zoster shot never ever had before. New worse lip 1st time appeared on lip 1-25-17. Still have outbreaks.
After receiving vaccine pt. began to notice increase pain & swelling following day. After 2 days came into office saw CRNP. Treated with Keflex 500 mg.
Patient developed lip tingling and a rash within 15 minutes after receiving vaccination.   Patient received 25mg PO Benadryl with improvement in her symptoms.
Incorrect dose was administered. 0.5 ml was administered. Correct dose is 0.25 ml.
I had congestion, headache, no fever. I went to the doctor because I thought I head cold. They tested me for COVID-19, it came back positive, I was prescribed Paxlovid. I did start feeling better within a couple of days. I tested negative within four days of starting the medication.
PT HAD SORE/ARM FOR A FEW DAYS FOLLOWING INJECTION. FEW DAYS LATER, HE SPIKED A FEVER AND DR ADVISED HIM TO GO TO ER. PT WAS DIAGNOSED WITH PNEUMONIA. SINCE THE INJECTION, PT STILL HAS PAIN AT INJECTION SITE AND SHOOTING PAIN FROM ARM TO SHOULDER TO NECK WHEN RAISING ARM (LIKE WHEN EATING)
This is a spontaneous report from a contactable nurse. A 18-year-old female patient of unknown race/ethnicity received on 07Mar2017 first single dose of TRUMENBA for immunization. Medical history and concomitant medications were not reported. On 07Mar2017, in the evening,  the patient experienced headache and chills, next morning she was fine. She completely recovered in Mar2017.